V Glaser. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Amyotrophic Lateral Sclerosis/therapyBiotechnologyClinical Trials as TopicDrug IndustryGrowth Substances/therapeutic useHumansInsulin-Like Growth Factor I/therapeutic useIntercellular Signaling Peptides and ProteinsRecombinant Proteins/therapeutic useTreatment FailureUnited StatesUnited States Food and Drug Administration
Substances： See more » Growth SubstancesIntercellular Signaling Peptides and ProteinsRecombinant ProteinsmyotrophinInsulin-Like Growth Factor I
Year: 1997 PMID： 9181559 DOI： 10.1038/nbt0697-495
Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908